Erythropoietin improves neuronal proliferation in dentate gyrus of hippocampal formation in an animal model of Alzheimer's disease
- PMID: 23326781
- PMCID: PMC3544128
- DOI: 10.4103/2277-9175.100157
Erythropoietin improves neuronal proliferation in dentate gyrus of hippocampal formation in an animal model of Alzheimer's disease
Abstract
Background: Alzheimer's disease (AD) is a prevalent disorder with severe learning and memory defects. Because it has been demonstrated that erythropoietin (EPO) has positive effects on the central nervous system, the aim of this study was to evaluate the effect of EPO on neuronal proliferation in dentate gyrus of hippocampal formation in a well-defined model for AD.
Materials and methods: A rat model of sporadic dementia of Alzheimer's type was established by a bilateral intracerebroventricular injection of streptozotocin (ICV-STZ). Impairment of learning and memory was confirmed 2 weeks after ICV-STZ injection by passive avoidance learning test and then rats were divided into fourgroups:Control, control-EPO, Alzheimer and Alzheimer-EPO. EPO was injected intraperitoneally every other day with a dose of 5000 IU/kg and, finally, the rats were anesthetized and decapitated for immunohistochemical study and neurogenesis investigation (by Ki67 method) in dentate gyrus of hippocampal formation.
Results: The results driven from the histological study showed that EPO significantly increases neuronal proliferation in dentate gyrus of hippocampus in the Alzheimer-EPO group compared with the control, control-EPO and Alzheimer groups; however, there were no differences between the other groups.
Conclusion: Our results show that even though EPO in intact animals doesnot change neurogenesis in dentate gyrus, it can nonetheless significantly increase neurogenesis if there is an underlying disorder like neurodegenerative diseases.
Keywords: Alzheimer's; erythropoietin; neuronal proliferation; rat; streptozotocin.
Conflict of interest statement
Figures



Similar articles
-
Effect of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) on learning and memory impairment and hippocampal apoptosis induced by intracerebroventricular administration of streptozotocin in rats.Behav Brain Res. 2020 Apr 20;384:112554. doi: 10.1016/j.bbr.2020.112554. Epub 2020 Feb 11. Behav Brain Res. 2020. PMID: 32057828
-
Neuroprotective effects of erythropoietin on Alzheimer's dementia model in rats.Adv Clin Exp Med. 2017 Jan-Feb;26(1):23-29. doi: 10.17219/acem/61044. Adv Clin Exp Med. 2017. PMID: 28397428
-
The effects of the 5-HT7 receptor on hippocampal long-term potentiation and apoptosis in a rat model of Alzheimer's disease.Brain Res Bull. 2017 Oct;135:85-91. doi: 10.1016/j.brainresbull.2017.10.004. Epub 2017 Oct 5. Brain Res Bull. 2017. PMID: 28987281
-
Erythropoietin improves synaptic plasticity and memory deficits by decrease of the neurotransmitter release probability in the rat model of Alzheimer's disease.Pharmacol Biochem Behav. 2015 Mar;130:15-21. doi: 10.1016/j.pbb.2014.12.011. Epub 2014 Dec 29. Pharmacol Biochem Behav. 2015. PMID: 25553822
-
Hippocampal neurogenesis: Learning to remember.Prog Neurobiol. 2016 Mar-May;138-140:1-18. doi: 10.1016/j.pneurobio.2015.12.006. Epub 2016 Feb 6. Prog Neurobiol. 2016. PMID: 26855369 Free PMC article. Review.
Cited by
-
Synergistic effects of GSK-3β and HDAC inhibitors in intracerebroventricular streptozotocin-induced cognitive deficits in rats.Naunyn Schmiedebergs Arch Pharmacol. 2015 Mar;388(3):337-49. doi: 10.1007/s00210-014-1081-2. Epub 2014 Dec 31. Naunyn Schmiedebergs Arch Pharmacol. 2015. PMID: 25547373
-
Prevention of Alzheimer's disease by treating mild cognitive impairment with combinations chosen from eight available drugs.Alzheimers Dement (N Y). 2019 Nov 16;5:780-788. doi: 10.1016/j.trci.2019.09.019. eCollection 2019. Alzheimers Dement (N Y). 2019. PMID: 31763432 Free PMC article. Review.
-
Erythropoietin as a Neuroprotective Molecule: An Overview of Its Therapeutic Potential in Neurodegenerative Diseases.ASN Neuro. 2019 Jan-Dec;11:1759091419871420. doi: 10.1177/1759091419871420. ASN Neuro. 2019. PMID: 31450955 Free PMC article. Review.
-
Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor.Neural Regen Res. 2017 Sep;12(9):1381-1389. doi: 10.4103/1673-5374.215240. Neural Regen Res. 2017. PMID: 29089974 Free PMC article. Review.
-
Current Evidence on the Protective Effects of Recombinant Human Erythropoietin and Its Molecular Variants against Pathological Hallmarks of Alzheimer's Disease.Pharmaceuticals (Basel). 2020 Nov 26;13(12):424. doi: 10.3390/ph13120424. Pharmaceuticals (Basel). 2020. PMID: 33255969 Free PMC article. Review.
References
-
- Herring A, Ambrée O, Tomm M, Habermann H, Sachser N, Paulus W, et al. Environmental enrichment enhances cellular plasticity in transgenic mice with Alzheimer-like pathology. Exp Neurol. 2009;216:184–92. - PubMed
-
- Bothwell M, Giniger E. Alzheimer's disease: Neurodevelopment converges with neurodegeneration. Cell. 2000;102:271–3. - PubMed
-
- Lasne F, de Ceaurriz J. Recombinant erythropoietin in urine-An artificial hormone taken to boost athletic performance can now be detected. Nature. 2000;405:635. - PubMed
-
- Kumral A, Uysal N, Tugyan K, Sonmez A, Yilmaz O, Gokmen N, et al. Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats. Behav Brain Res. 2004;153:77–86. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials